GILD stock Archives

May 2, 2020June 11, 2020

Gilead prepared to surge after FDA approval of COVID-19 treatment Remdesivir

Trump announced on Friday that the US Food and Drug Administration has cleared the emergency use of Remdesivir as a COVID-19 treatment. Gilead Sciences (NASDAQ:GILD) will play a vital role in producing 1.5 million doses for patients across the US suffering critical complications from COVID-19.…

April 18, 2020June 11, 2020

How Gilead drove a US rally based on optimism.

The Dow Jones rallied upwards of 700 points on Friday as Gilead’s (NASDAQ:GILD) “Wonder Drug” has shown promising results according to a Chicago University source. The video of Infectious Disease Professor Kathleen Mullane, goes into some detail over the success of Remdesivir in recent trials with patients reporting fast recoveries from COVID-19.…